Ghisoni, E
52  Ergebnisse:
Personensuche X
?
1

5P Tumor microenvironment cellular crosstalk predicts respo..:

Dangaj, D. ; Barras, D. ; Ghisoni, E....
Immuno-Oncology and Technology.  16 (2022)  - p. 100110 , 2022
 
?
2

125P A phase IIa study of the novel immunogenic cell death ..:

Imbimbo, M. ; Ghisoni, E. ; Mulvey, A....
Immuno-Oncology and Technology.  16 (2022)  - p. 100237 , 2022
 
?
4

Late-onset and long-lasting immune-related adverse events f..:

Ghisoni, E. ; Wicky, A. ; Bouchaab, H....
European Journal of Cancer.  149 (2021)  - p. 153-164 , 2021
 
?
7

Ki67 as a Predictor of Response to PARP Inhibitors in Plati..:

Tuninetti, V ; Ghisoni, E ; Pignata, S...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers15041032.  , 2023
 
?
8

Low-Dose Radiotherapy Reverses Tumor Immune Desertification..:

Herrera, F.G ; Ronet, C ; Ochoa de Olza, M...
info:eu-repo/semantics/altIdentifier/doi/10.1158/2159-8290.CD-21-0003.  , 2022
 
?
9

Patient-reported outcomes in adoptive cell-therapy trials: ..:

Ghisoni, E ; Morotti, M ; Colomer-Lahiguera, S...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jitc-2022-006082.  , 2022
 
?
10

PARP inhibition in ovarian cancer: what is still missing?:

Morotti, M ; Ghisoni, E
info:eu-repo/semantics/altIdentifier/pissn/0392-2936.  , 2022
 
?
12

Cell-autonomous inflammation of BRCA1-deficient ovarian can..:

Bruand, M ; Barras, D ; Mina, M...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.celrep.2021.109412.  , 2021
 
?
13

Late-onset and long-lasting immune-related adverse events f..:

Ghisoni E ; Wicky A ; Bouchaab H...
info:eu-repo/semantics/altIdentifier/pmid/33865201.  , 2021
 
?
15

Hypersensitivity to platinum salts according to BRCA status..:

Giannone G ; Scotto G ; Katsaros D...
info:eu-repo/semantics/altIdentifier/pmid/33896588.  , 2021
 
1-15